Skip to main content

Advertisement

Table 1 Distribution of low and high SRAP cases in case subgroups

From: Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients

Case subgroups Low SRAP High SRAP Total Pvalue
  n (%) n (%)   
ER - 72 (71) 29 (29) 101 < 0.0001
ER+ 115 (42) 156 (58) 271  
PR - 78 (67) 37 (33) 115 0.0053
PR+ 112(44) 145 (56) 257  
Node - 95 (55) 80 (45) 172 0.2545
Node + 95 (48) 102 (52) 200  
Low (3-5) 30 (39) 47 (61) 77 < 0.0001
Med (6-7) 97 (47) 109 (53) 206  
High (8-9) 63 (71) 26 (29) 89  
Low size (≤ 2.5 cm) 105 (54) 90 (46) 195 0.2992
High size (> 2.5 cm) 85 (48) 92 (52) 177  
Age ≤ 64 113 (60) 77 (40) 190 0.0013
Age > 64 77 (42) 105 (58) 182  
Total 190 182 372  
  1. P-values correspond to Fisher's exact test. ER = estrogen receptor; PR = progesterone receptor; SRAP = steroid receptor RNA activator protein; + = positive; - = negative.